News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Polycythemia ups risk of MACE, VTE in men on testosterone therapy
06 Jun 2022
Men receiving testosterone therapy (TT) who develop polycythemia are at greater risk for major adverse cardiovascular events (MACE) and venous thromboembolism (VTE) in the first year of therapy, according to a recent study.
06 Jun 2022







